_hanorphwaspanimaticvid.jpg "HanOrphWaspAnimaticVid from orph Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 17 sec
✓ Published: 20-May-2018
✓ Published: 20-May-2018
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_open-orphan-world39s-first-covid-19-characterisation-study.webp "Open Orphan plc (LON:ORPH) Executive Chairman Cathal Friel joins DirectorsTalk Interviews to discuss results from the world's first COVID-19 characterisation study.nnCathal explains what these results mean for Open Orphan, plans to initiate the next phase of the Human Challenge Programme, studies to approve new vaccines and antivirals and with 95% of 2022 targeted revenues contracted being non-Covid revenue can we expect some COVID-19 revenue this year.")
_em-2018-recomece.webp "Cotiporã | Rio Grande do Sul | ORPHdrones.comnnO que queremos para 2018? Este trabalho é resultado de uma parceria entre Prefeitura Municipal de Cotiporã e ORPHdrones.")
_open-orphan-rsv-human-challenge-study.webp "Open Orphan (LON:ORPH) Executive Chairman Cathal Friel joins DirectorsTalk to discuss the signing of a new contract with a European Biotech Company for the provision of a RSV human challenge study. Cathal explains what the study entails, what it means for the company, the timescales involved and what else is going on in the company.")
_blackorph.webp "BlackOrph from orph")
_orph20-detlev-parrow.webp "Orph20: Detlev Parrow from orph")
_s02-e09-orph.webp "S02 E09 Orph from orph")
_thesis-morph.webp "A short video for sciarc undergrad thesis 2014")
_open-orphan-investor-presentation-2021-a-good-year-2022-will-be-a-great-year.webp "Open Orphan plc (LON:ORPH) Chief Executive Officer Yamin ‘Mo’ Khan talks through the FY2021 Financial Results and the outlook for 2022.nnMo covers topics:nThe Vision,nThe Numbers,nOverview,nKey Strategic Value Adding Initiatives,nSummary Financial Highlights,nAttractive Market Dynamics,nGrowth of Vaccines & Anti-Virals,nOutlook,nInvestment CasennOpen Orphan (LON ORPH) is the world leader in testing infectious & respiratory disease products using human challenge studies addressing the")
⏲ 6 min 47 sec ✓ 09-Jun-2022
_open-orphan-world39s-first-covid-19-characterisation-study.jpg)
_em-2018-recomece.jpg)
_open-orphan-rsv-human-challenge-study.jpg)
_blackorph.jpg)
_orph20-detlev-parrow.jpg)
_s02-e09-orph.jpg)
_thesis-morph.jpg)
_open-orphan-investor-presentation-2021-a-good-year-2022-will-be-a-great-year.jpg)
![[+]](/images/menu.gif){kind=small}